Dr Ian Irving

Fellow, Royal College of Pathologists of Australasia, 2001.

Fellowship of the Royal Australasian College of Physicians, 2000.

Bachelor of Medicine, Bachelor of Surgery, University of Queensland, 1991.

• Effects of intensive induction and consolidation chemotherapy with idarubicin and high dose cytarabine on minimal residual disease levels in newly diagnosed adult precursor-B acute lymphoblastic leukemia. Kenneth F. Bradstock, Alec Morley, Karen Byth, Jeff Szer, Ian Prosser, Paul Cannell, Ian Irving, John F. Seymour. Contemporary Clinical Trials Communications, Volume 4, 15 December 2016, 9-13

• An imatinib-only window followed by imatinib and chemotherapy for Philadelpha chromosome-postive leukaemia:long term results of the CMLALL1 trial. Lickliter JD, Taylor K, Szer J, Grigg A, Arthur C, Hughes TP, Durrant S, Filshie R, Irving I, Seldon M, Ellacott J, Boyd AW, D’Rozario J, Rooney K, Lynch K, Bradstock K; Australiasian Leukaemia and Lymphoma Group. Leuk Lymphoma 2015 Mar; 56 (3): 630-638

• Screening whole spine magnetic resonance imaging in multiple myeloma. Wight J, Stillwell A, Morris E, Grant B, Lai HC, Irving I. Internal Med J. 2015 Jul; 45 (7): 762-765

• Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol. Hocking J, Schwarer AP, Gasiorowski R, Patil S, Avery S, Gibson J, Iland H, Ho PJ, Joshua D, Muirhead J, Lai H, Irving I. Leuk Lymphoma 2014 Dec; 55 (12): 2201-2207

• Isolated intracranial myeloid sarcoma. Hodges G, Lai HC, Irving I, Macloud M, Korah I, Ramuz O, Morris E. Pathology 2012 Oct; 44 (6): 571-574